p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer

NCT00844506 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: P53-SLP vaccine
DRUG: Cyclophosphamide

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]